Predicting biomarkers in intact older adults and those with amnestic Mild Cognitive Impairment, and mild Alzheimer’s Disease using the Repeatable Battery for the Assessment of Neuropsychological Status

References

• ADNI2. (2020). Alzheimer’s Disease neuroimaging initiative: ADNI2 procedures manual. Retrieved May 21, from https://adni.loni.usc.edu/wp-content/uploads/2008/07/adni2-procedures-manual.pdf
   Google Scholar
• Beach, T. G., Thal, D. R., Zanette, M., Smith, A., & Buckley, C. (2016). Detection of striatal amyloid plaques with [18F]flutemetamol: Validation with postmortem histopathology. Journal of Alzheimer’s Disease, 52(3), 863–873. https://doi.org/https://doi.org/10.3233/JAD-150732
   PubMed Web of Science ®Google Scholar
• Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Aggarwal, N. T., Arnold, S. E., Cochran, E. J., Berry-Kravis, E., & Bienias, J. L. (2003). Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer’s disease. Neurology, 60(2), 246–252. https://doi.org/https://doi.org/10.1212/01.wnl.0000042478.08543.f7
   PubMed Web of Science ®Google Scholar
• Biogen. (2020, August 7). 221AD302 phase 3 study of aducanumab (BIIB037) in Early Alzheimer’s Disease (EMERGE). US National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT02484547
   Google Scholar
• Bland, J. M., & Altman, D. G. (2011). Correlation in restricted ranges of data. Bmj, 342(mar11 1), d556. https://doi.org/https://doi.org/10.1136/bmj.d556
   PubMedGoogle Scholar
• Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes [Review]. Acta Neuropathologica, 82(4), 239–259. https://doi.org/https://doi.org/10.1007/BF00308809
   PubMed Web of Science ®Google Scholar
• Burton, R. L., Enright, J., O’Connell, M. E., Lanting, S., & Morgan, D. (2015). RBANS embedded measures of suboptimal effort in dementia: Effort scale has a lower failure rate than the effort index [Research Support, Non-U.S. Gov’t]. Archives of Clinical Neuropsychology, 30(1), 1–6. https://doi.org/https://doi.org/10.1093/arclin/acu070
   PubMed Web of Science ®Google Scholar
• Caldwell, J. Z. K., Berg, J. L., Cummings, J. L., & Banks, S. J., & Alzheimer’s Disease Neuroimaging, I. (2017). Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume. Alzheimer’s Research & Therapy, 9(1), 72. https://doi.org/https://doi.org/10.1186/s13195-017-0300-8
   PubMedGoogle Scholar
• Caselli, R. J., Dueck, A. C., Osborne, D., Sabbagh, M. N., Connor, D. J., Ahern, G. L., Baxter, L. C., Rapcsak, S. Z., Shi, J., Woodruff, B. K., Locke, D. E. C., Snyder, C. H., Alexander, G. E., Rademakers, R., & Reiman, E. M. (2009). Longitudinal modeling of age-related memory decline and the APOE ε4 effect. New England Journal of Medicine, 361(3), 255–263. https://doi.org/https://doi.org/10.1056/NEJMoa0809437
   PubMed Web of Science ®Google Scholar
• Choe, Y. M., Sohn, B. K., Choi, H. J., Byun, M. S., Seo, E. H., Han, J. Y., Kim, Y. K., Yoon, E. J., Lee, J.-M., Park, J., Woo, J. I., & Lee, D. Y. (2014). Association of homocysteine with hippocampal volume independent of cerebral amyloid and vascular burden. Neurobiology of Aging, 35(7), 1519–1525. https://doi.org/https://doi.org/10.1016/j.neurobiolaging.2014.01.013
   PubMed Web of Science ®Google Scholar
• Clark, J. H., Hobson, V. L., & O’Bryant, S. E. (2010). Diagnostic accuracy of percent retention scores on RBANS verbal memory subtests for the diagnosis of Alzheimer’s disease and mild cognitive impairment [Comparative Study]. Archives of Clinical Neuropsychology, 25(4), 318–326. https://doi.org/https://doi.org/10.1093/arclin/acq023
   PubMed Web of Science ®Google Scholar
• Cooley, S. A., Heaps, J. M., Bolzenius, J. D., Salminen, L. E., Baker, L. M., Scott, S. E., & Paul, R. H. (2015). Longitudinal change in performance on the montreal cognitive assessment in older adults [Research Support, N.I.H., Extramural]. The Clinical Neuropsychologist, 29(6), 824–835. https://doi.org/https://doi.org/10.1080/13854046.2015.1087596
   PubMed Web of Science ®Google Scholar
• Cosentino, S., Scarmeas, N., Helzner, E., Glymour, M. M., Brandt, J., Albert, M., Blacker, D., & Stern, Y. (2008). APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology, 70(19 Pt 2), 1842–1849. https://doi.org/https://doi.org/10.1212/01.wnl.0000304038.37421.cc
   PubMed Web of Science ®Google Scholar
• De Jager, C. A., Hogervorst, E., Combrinck, M., & Budge, M. M. (2003). Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer’s disease. Psychological Medicine, 33(6), 1039–1050. https://doi.org/https://doi.org/10.1017/s0033291703008031
   PubMed Web of Science ®Google Scholar
• Duff, K., Foster, N. L., Dennett, K., Hammers, D. B., Zollinger, L. V., Christian, P. E., Butterfield, R. I., Beardmore, B. E., Wang, A. Y., Morton, K. A., & Hoffman, J. M. (2013). Amyloid deposition and cognition in older adults: The effects of premorbid intellect. Archives of Clinical Neuropsychology, 28(7), 665–671. https://doi.org/https://doi.org/10.1093/arclin/act047
   PubMed Web of Science ®Google Scholar
• Duff, K., Hobson, V. L., Beglinger, L. J., & O’Bryant, S. E. (2010). Diagnostic accuracy of the RBANS in mild cognitive impairment: Limitations on assessing milder impairments. Archives of Clinical Neuropsychology, 25(5), 429–441. https://doi.org/https://doi.org/10.1093/arclin/acq045
   PubMed Web of Science ®Google Scholar
• Duff, K., Humphreys Clark, J. D., O’Bryant, S. E., Mold, J. W., Schiffer, R. B., & Sutker, P. B. (2008). Utility of the RBANS in detecting cognitive impairment associated with Alzheimer’s disease: Sensitivity, specificity, and positive and negative predictive powers. Archives of Clinical Neuropsychology, 23(5), 603–612. https://doi.org/https://doi.org/10.1016/j.acn.2008.06.004
   PubMed Web of Science ®Google Scholar
• Duff, K., & Ramezani, A. (2015). Regression-based normative formulae for the repeatable battery for the assessment of neuropsychological status for older adults. Archives of Clinical Neuropsychology, 30(7), 600–604. https://doi.org/https://doi.org/10.1093/arclin/acv052
   PubMed Web of Science ®Google Scholar
• England, H. B., Gillis, M. M., & Hampstead, B. M. (2014). RBANS memory indices are related to medial temporal lobe volumetrics in healthy older adults and those with mild cognitive impairment [Research Support, N.I.H., Extramural Research Support, U.S. Gov’t, Non-P.H.S.]. Archives of Clinical Neuropsychology, 29(4), 322–328. https://doi.org/https://doi.org/10.1093/arclin/acu012
   PubMed Web of Science ®Google Scholar
• Enright, J., O’Connell, M. E., MacKinnon, S., & Morgan, D. G. (2015). Predictors of completion of executive-functioning tasks in a memory clinic dementia sample [Research Support, Non-U.S. Gov’t]. Applied Neuropsychology: Adult, 22(6), 459–464. https://doi.org/https://doi.org/10.1080/23279095.2014.992070
   PubMed Web of Science ®Google Scholar
• Falgas, N., Sanchez-Valle, R., Bargallo, N., Balasa, M., Fernandez-Villullas, G., Bosch, B., Llado, A., Antonell, A., Muñoz-García, C., León, M., Grau, O., Castellví, M., Coll-Padrós, N., Rami, L., Redolfi, A., Lladó, A., & Olives, J. (2019). Hippocampal atrophy has limited usefulness as a diagnostic biomarker on the early onset Alzheimer’s disease patients: A comparison between visual and quantitative assessment. NeuroImage: Clinical, 23, 101927. https://doi.org/https://doi.org/10.1016/j.nicl.2019.101927
   PubMed Web of Science ®Google Scholar
• Fischl, B., & Dale, A. M. (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences, 97(20), 11050–11055. https://doi.org/https://doi.org/10.1073/pnas.200033797
   PubMed Web of Science ®Google Scholar
• Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., Montillo, A., Makris, N., Rosen, B., & Dale, A. M. (2002). Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron, 33(3), 341–355. https://doi.org/https://doi.org/10.1016/s0896-6273(02)00569-x
   PubMed Web of Science ®Google Scholar
• Fischl, B., van der Kouwe, A., Destrieux, C., Halgren, E., Segonne, F., Salat, D. H., & Dale, A. M. (2004). Automatically parcellating the human cerebral cortex. Cerebral Cortex, 14(1), 11–22. https://doi.org/https://doi.org/10.1093/cercor/bhg087
   PubMed Web of Science ®Google Scholar
• Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198. https://doi.org/https://doi.org/10.1016/0022-3956(75)90026-6
   PubMed Web of Science ®Google Scholar
• Frisoni, G. B., Fox, N. C., Jack, C. R., Jr., Scheltens, P., & Thompson, P. M. (2010). The clinical use of structural MRI in Alzheimer disease. Nature Reviews Neurology, 6(2), 67–77. https://doi.org/https://doi.org/10.1038/nrneurol.2009.215
   PubMed Web of Science ®Google Scholar
• Ge, T., Sabuncu, M. R., Smoller, J. W., Sperling, R. A., & Mormino, E. C., & Alzheimer’s Disease Neuroimaging, I. (2018). Dissociable influences of APOE epsilon4 and polygenic risk of AD dementia on amyloid and cognition. Neurology, 90(18), e1605–e1612. doi:https://doi.org/10.1212/WNL.0000000000005415.
   PubMed Web of Science ®Google Scholar
• Gibbons, L. E., Carle, A. C., Mackin, R. S., Harvey, D., Mukherjee, S., Insel, P., Curtis, S. M., Mungas, D., & Crane, P. K., & Alzheimer’s Disease Neuroimaging, I. (2012). A composite score for executive functioning, validated in Alzheimer’s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging and Behavior, 6(4), 517–527. https://doi.org/https://doi.org/10.1007/s11682-012-9176-1
   PubMed Web of Science ®Google Scholar
• Hammers, D. B., Atkinson, T. J., Dalley, B. C., Suhrie, K. R., Beardmore, B. E., Burrell, L. D., Horn, K. P., Rasmussen, K. M., Foster, N. L., Duff, K., & Hoffman, J. M. (2017). Relationship between 18F-Flutemetamol uptake and RBANS performance in non-demented community-dwelling older adults. The Clinical Neuropsychologist, 31(3), 531–543. https://doi.org/https://doi.org/10.1080/13854046.2016.1278039
   PubMed Web of Science ®Google Scholar
• Hammers, D. B., Atkinson, T. J., Dalley, B. C. A., Suhrie, K. R., Horn, K. P., Rasmussen, K. M., Beardmore, B. E., Burrell, L. D., Duff, K., & Hoffman, J. M. (2017). Amyloid positivity using [18F]Flutemetamol-PET and cognitive deficits in nondemented community-dwelling older adults. American Journal of Alzheimer’s Disease & Other Dementiasr, 32(6), 320–328. https://doi.org/https://doi.org/10.1177/1533317517698795
   PubMed Web of Science ®Google Scholar
• Hammers, D. B., Foster, N. L., Hoffman, J. M., Greene, T. H., & Duff, K. (2019). Neuropsychological, psychiatric, and functional correlates of clinical trial enrollment. The Journal of Prevention of Alzheimer’s Disease, 6(4), 242–247. https://doi.org/https://doi.org/10.14283/jpad.2019.38
   PubMed Web of Science ®Google Scholar
• Heyanka, D. J., Scott, J. G., & Adams, R. L. (2015). Improving the diagnostic accuracy of the RBANS in mild cognitive impairment with construct-consistent measures. Applied Neuropsychology: Adult, 22(1), 32–41. https://doi.org/https://doi.org/10.1080/23279095.2013.827574
   PubMed Web of Science ®Google Scholar
• Hobson, V. L., Hall, J. R., Humphreys-Clark, J. D., Schrimsher, G. W., & O’Bryant, S. E. (2010). Identifying functional impairment with scores from the repeatable battery for the assessment of neuropsychological status (RBANS). International Journal of Geriatric Psychiatry, 25(5), 525–530. https://doi.org/https://doi.org/10.1002/gps.2382
   PubMed Web of Science ®Google Scholar
• Holtzman, D. M., Herz, J., & Bu, G. (2012). Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine, 2(3), a006312. https://doi.org/https://doi.org/10.1101/cshperspect.a006312
   PubMed Web of Science ®Google Scholar
• Hyman, B. T., Van Hoesen, G. W., & Damasio, A. R. (1990). Memory-related neural systems in Alzheimer’s disease: An anatomic study [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. Neurology, 40(11), 1721–1730. https://doi.org/https://doi.org/10.1212/WNL.40.11.1721
   PubMed Web of Science ®Google Scholar
• Insel, P. S., Mattsson, N., Mackin, R. S., Kornak, J., Nosheny, R., Tosun-Turgut, D., Donohue, M. C., Aisen, P. S., & Weiner, M. W., & Alzheimer’s Disease Neuroimaging, I. (2015). Biomarkers and cognitive endpoints to optimize trials in Alzheimer’s disease. Annals of Clinical and Translational Neurology, 2(5), 534–547. https://doi.org/https://doi.org/10.1002/acn3.192
   PubMed Web of Science ®Google Scholar
• Jack, C. R., Jr., Wiste, H. J., Weigand, S. D., Knopman, D. S., Vemuri, P., Mielke, M. M., Lowe, V., Senjem, M. L., Gunter, J. L., Machulda, M. M., Gregg, B. E., Pankratz, V. S., Rocca, W. A., & Petersen, R. C. (2015). Age, Sex, and APOE ε4 effects on memory, brain structure, and β-Amyloid across the adult life span. JAMA Neurology, 72(5), 511–519. https://doi.org/https://doi.org/10.1001/jamaneurol.2014.4821
   PubMed Web of Science ®Google Scholar
• Jiang, L., Cheng, Y., Li, Q., Tang, Y., Shen, Y., Li, T., Li, Q., Li, T., Feng, W., Cao, X., Wu, W., Wang, J., & Li, C. (2014). Cross-sectional study of the association of cognitive function and hippocampal volume among healthy elderly adults. Shanghai archives of Psychiatry, 26(5), 280–287. https://doi.org/https://doi.org/10.11919/j.1002-0829.214036
   PubMedGoogle Scholar
• Karantzoulis, S., Novitski, J., Gold, M., & Randolph, C. (2013). The repeatable battery for the assessment of neuropsychological status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer’s disease [Evaluation Studies Multicenter Study]. Archives of Clinical Neuropsychology, 28(8), 837–844. https://doi.org/https://doi.org/10.1093/arclin/act057
   PubMed Web of Science ®Google Scholar
• Kim, J., Basak, J. M., & Holtzman, D. M. (2009). The role of apolipoprotein E in Alzheimer’s disease. Neuron, 63(3), 287–303. https://doi.org/https://doi.org/10.1016/j.neuron.2009.06.026
   PubMed Web of Science ®Google Scholar
• Kim, J. S. (2020). Tau imaging: New era of neuroimaging for Alzheimer’s Disease. Nuclear Medicine and Molecular Imaging, 54(4), 161–162. https://doi.org/https://doi.org/10.1007/s13139-020-00657-4
   PubMed Web of Science ®Google Scholar
• Lim, Y. Y., Williamson, R., Laws, S. M., Villemagne, V. L., Bourgeat, P., Fowler, C., … Group, A. R. (2017). Effect of APOE genotype on amyloid deposition, brain volume, and memory in cognitively normal older individuals. Journal of Alzheimer’s Disease, 58(4), 1293–1302. https://doi.org/https://doi.org/10.3233/JAD-170072
   PubMed Web of Science ®Google Scholar
• Lundqvist, R., Lilja, J., Thomas, B. A., Lotjonen, J., Villemagne, V. L., Rowe, C. C., & Thurfjell, L. (2013). Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data. Journal of Nuclear Medicine, 54(8), 1472–1478. https://doi.org/https://doi.org/10.2967/jnumed.112.115006
   PubMed Web of Science ®Google Scholar
• Mayeux, R., Stern, Y., Ottman, R., Tatemichi, T. K., Tang, M. X., Maestre, G., Ngai, C., Tycko, B., & Ginsberg, H. (1993). The apolipoprotein epsilon 4 allele in patients with Alzheimer’s disease. Annals of Neurology, 34(5), 752–754. https://doi.org/https://doi.org/10.1002/ana.410340527
   PubMed Web of Science ®Google Scholar
• McDermott, A. T., & DeFilippis, N. A. (2010). Are the indices of the RBANS sufficient for differentiating Alzheimer’s disease and subcortical vascular dementia? Archives of Clinical Neuropsychology, 25(4), 327–334. https://doi.org/https://doi.org/10.1093/arclin/acq028
   PubMed Web of Science ®Google Scholar
• Morgan, D. R., Linck, J., Scott, J., Adams, R., & Mold, J. (2010). Assessment of the RBANS Visual and Verbal Indices in a sample of neurologically impaired elderly participants. The Clinical Neuropsychologist, 24(8), 1365–1378. https://doi.org/https://doi.org/10.1080/13854046.2010.516769
   PubMed Web of Science ®Google Scholar
• Mormino, E. C., Betensky, R. A., Hedden, T., Schultz, A. P., Amariglio, R. E., Rentz, D. M., … Sperling, R. A. (2014). Synergistic effect of beta-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurology, 71(11), 1379–1385. https://doi.org/https://doi.org/10.1001/jamaneurol.2014.2031
   PubMed Web of Science ®Google Scholar
• Morris, J. C. (1993). The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43(11), 2412–2414. https://doi.org/https://doi.org/10.1212/WNL.43.11.2412-a
   PubMed Web of Science ®Google Scholar
• O’Mahar, K. M., Duff, K., Scott, J. G., Linck, J. F., Adams, R. L., & Mold, J. W. (2012). Brief report: The temporal stability of the Repeatable Battery for the Assessment of Neuropsychological Status Effort Index in geriatric samples [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Archives of Clinical Neuropsychology, 27(1), 114–118. https://doi.org/https://doi.org/10.1093/arclin/acr072
   PubMed Web of Science ®Google Scholar
• Ottoy, J., Niemantsverdriet, E., Verhaeghe, J., De Roeck, E., Struyfs, H., Somers, C., … Staelens, S. (2019). Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18)F-FDG-PET imaging. NeuroImage: Clinical, 22, 101771. https://doi.org/https://doi.org/10.1016/j.nicl.2019.101771
   PubMed Web of Science ®Google Scholar
• Paul, R., Lane, E. M., Tate, D. F., Heaps, J., Romo, D. M., Akbudak, E., Niehoff, J., & Conturo, T. E. (2011). Neuroimaging signatures and cognitive correlates of the Montreal cognitive assessment screen in a nonclinical elderly sample [Research Support, N.I.H., Extramural]. Archives of Clinical Neuropsychology, 26(5), 454–460. https://doi.org/https://doi.org/10.1093/arclin/acr017
   PubMed Web of Science ®Google Scholar
• Petersen, R. C., Jack, C. R., Jr., Xu, Y. C., Waring, S. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., Boeve, B. F., & Kokmen, E. (2000). Memory and MRI-based hippocampal volumes in aging and AD. Neurology, 54(3), 581–587. https://doi.org/https://doi.org/10.1212/wnl.54.3.581
   PubMed Web of Science ®Google Scholar
• Petersen, R. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., Schaid, D. J., Thibodeau, S. N., & Kurland, L. T. (1995). Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals. JAMA: The Journal of the American Medical Association, 273(16), 1274–1278. https://doi.org/https://doi.org/10.1001/jama.1995.03520400044042
   PubMed Web of Science ®Google Scholar
• Phillips, R., Qi, G., Collinson, S. L., Ling, A., Feng, L., Cheung, Y. B., & Ng, T. P. (2015). The minimum clinically important difference in the repeatable battery for the assessment of neuropsychological status. The Clinical Neuropsychologist, 29(7), 905–923. https://doi.org/https://doi.org/10.1080/13854046.2015.1107137
   PubMed Web of Science ®Google Scholar
• Randolph, C. (2012). Repeatable battery for the assessment of neuropsychological status. The Psychological Corporation.
   Google Scholar
• Salthouse, T. A. (2009). Decomposing age correlations on neuropsychological and cognitive variables. Journal of the International Neuropsychological Society, 15(5), 650–661. https://doi.org/https://doi.org/10.1017/S1355617709990385
   PubMed Web of Science ®Google Scholar
• Schmitt, A. L., Livingston, R. B., Smernoff, E. N., Reese, E. M., Hafer, D. G., & Harris, J. B. (2010). Factor analysis of the repeatable battery for the assessment of neuropsychological status (RBANS) in a large sample of patients suspected of dementia. Applied Neuropsychology, 17(1), 8–17. https://doi.org/https://doi.org/10.1080/09084280903297719
   PubMed Web of Science ®Google Scholar
• Small, B. J., Rosnick, C. B., Fratiglioni, L., & Backman, L. (2004). Apolipoprotein E and cognitive performance: A meta-analysis. Psychology and Aging, 19(4), 592–600. https://doi.org/https://doi.org/10.1037/0882-7974.19.4.592
   PubMed Web of Science ®Google Scholar
• Sunderland, J. J., & Christian, P. E. (2015). Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom. Journal of Nuclear Medicine, 56(1), 145–152. https://doi.org/https://doi.org/10.2967/jnumed.114.148056
   PubMed Web of Science ®Google Scholar
• Teng, E., Ward, M., Manser, P. T., Sanabria-Bohorquez, S., Ray, R. D., Wildsmith, K. R., Baker, S., Kerchner, G. A., & Weimer, R. M. (2019). Cross-sectional associations between [(18)F]GTP1 tau PET and cognition in Alzheimer’s disease. Neurobiology of Aging, 81, 138–145. https://doi.org/https://doi.org/10.1016/j.neurobiolaging.2019.05.026
   PubMed Web of Science ®Google Scholar
• Thaler, N. S., Hill, B. D., Duff, K., Mold, J., & Scott, J. G. (2015). Repeatable battery for the assessment of neuropsychological status (RBANS) intraindividual variability in older adults: Associations with disease and mortality. Journal of Clinical and Experimental Neuropsychology, 37(6), 622–629. https://doi.org/https://doi.org/10.1080/13803395.2015.1039962
   PubMed Web of Science ®Google Scholar
• Thurfjell, L., Lilja, J., Lundqvist, R., Buckley, C., Smith, A., Vandenberghe, R., & Sherwin, P. (2014). Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: Concordance with visual image reads. Journal of Nuclear Medicine, 55(10), 1623–1628. https://doi.org/https://doi.org/10.2967/jnumed.114.142109
   PubMed Web of Science ®Google Scholar
• Troyer, A. K., Murphy, K. J., Anderson, N. D., Craik, F. I., Moscovitch, M., Maione, A., & Gao, F. (2012). Associative recognition in mild cognitive impairment: Relationship to hippocampal volume and apolipoprotein E. Neuropsychologia, 50(14), 3721–3728. https://doi.org/https://doi.org/10.1016/j.neuropsychologia.2012.10.018
   PubMed Web of Science ®Google Scholar
• U.S. Bureau of Labor Statistics. (2016). Volunteering in the United States, 2015 https://www.bls.gov/news.release/volun.nr0.htm
   Google Scholar
• Van Hoesen, G. W., Hyman, B. T., & Damasio, A. R. (1991). Entorhinal cortex pathology in Alzheimer’s disease [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. Review]. Hippocampus, 1(1), 1–8. https://doi.org/https://doi.org/10.1002/hipo.450010102
   PubMedGoogle Scholar
• Vandenberghe, R., Van Laere, K., Ivanoiu, A., Salmon, E., Bastin, C., Triau, E., Hasselbalch, S., Law, I., Andersen, A., Korner, A., Minthon, L., Garraux, G., Nelissen, N., Bormans, G., Buckley, C., Owenius, R., Thurfjell, L., Farrar, G., & Brooks, D. J. (2010). 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial. Annals of Neurology, 68(3), 319–329. https://doi.org/https://doi.org/10.1002/ana.22068
   PubMed Web of Science ®Google Scholar
• Villemagne, V. L., & Okamura, N. (2016). Tau imaging in the study of ageing, Alzheimer’s disease, and other neurodegenerative conditions. Current Opinion in Neurobiology, 36, 43–51. https://doi.org/https://doi.org/10.1016/j.conb.2015.09.002
   PubMed Web of Science ®Google Scholar
• Wechsler, D. (1987). Manual for the Weschler Memory Scale - Revised. The Psychological Corporation.
   Google Scholar
• Wessels, A. M., Tariot, P. N., Zimmer, J. A., Selzler, K. J., Bragg, S. M., Andersen, S. W., … Sims, J. R. (2020). Efficacy and safety of lanabecestat for treatment of early and mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ randomized clinical trials. JAMA Neurology, 77(2), 199–209. https://doi.org/https://doi.org/10.1001/jamaneurol.2019.3988
   PubMed Web of Science ®Google Scholar
• Wilkinson, G. S., & Robertson, G. J. (2006). WRAT 4: Wide range achievement test, professional manual. Psychological Assessment Resources, Inc.
   Google Scholar
• Wolk, D. A., Price, J. C., Saxton, J. A., Snitz, B. E., James, J. A., Lopez, O. L., … De-Kosky, S. T. (2009). Amyloid imaging in mild cognitive impairment subtypes. Annals of Neurology, 65(5), 557–568. https://doi.org/https://doi.org/10.1002/ana.21598
   PubMed Web of Science ®Google Scholar
• Wu, L., Rowley, J., Mohades, S., Leuzy, A., Dauar, M. T., Shin, M., … Rosa-Neto, P. (2012). Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment [Clinical Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. PLoS One, 7(10), e47905. https://doi.org/https://doi.org/10.1371/journal.pone.0047905
   PubMed Web of Science ®Google Scholar
• Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982). Development and validation of a geriatric depression screening scale: A preliminary report. Journal of Psychiatric Research, 17(1), 37–49. https://doi.org/https://doi.org/10.1016/0022-3956(82)90033-4
   PubMed Web of Science ®Google Scholar
• Yester, M., Al-Senan, R., & White, S. (2014). NEMA testing of GE Discovery 710 PET scanner compared to a simplified protocol for routine testing of PET scanners. Journal of Nuclear Medicine, 55, 2157.
   Google Scholar
• Rabipour S, Rajagopal S, Yu E, Pasvanis S, Lafaille-Magnan ME, Breitner J; PREVENT-AD Research Group, and Rajah MN. APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset. J Alzheimers Dis. 2020;76(1):97–119.
   PubMed Web of Science ®Google Scholar